Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2022
  • Volume: 15
  • Issue: 11

Potential matrix metalloproteinase-9 inhibitor of aurone compound isolated from Sterculia quadrifida leaves: In-vitro and In-silico studies

  • Author:
  • Rollando Rollando1,*, Warsito Warsito2, Masruri Masruri3, Nashi Widodo4
  • Total Page Count: 5
  • Page Number: 5250 to 5254

1Pharmacy Department Faculty of Science and Technology, Ma Chung University, Malang, 65151, Indonesia

2Doctoral Student, Chemistry Department Faculty of Mathematics and Natural Sciences, Brawijaya University, Malang, 65145, Indonesia

3Chemistry Department Faculty of Mathematics and Natural Sciences, Brawijaya University, Malang, 65145, Indonesia

4Biology Department Faculty of Mathematics and Natural Sciences, Brawijaya University, Malang, 65145, Indonesia

*Corresponding Author E-mail: ro.llando@machung.ac.id

Online published on 3 March, 2023.

Abstract

In our previous study, aurone compound were found in the n-butanol fraction of Sterculia quadrifida leaves. The aurone compound (compound 1) had high cytotoxic activity in cell lines with IC50 values of 4.05, 12.53, 15.38, and 25.91 μg/mL in 4T1, MCF7, MDA-MB-435, T47D, respectively. In this study, we performed the MMP-9 enzyme inhibition test with FRET assay, and to deepen the mechanism of action of the compounds use molecular docking and molecular dynamics. The results showed that compound 1 had the MMP-9 enzyme inhibition of 91.23% and IC50 48.27%. Furthermore, molecular docking and molecular dynamic simulation suggest compound 1 interacts firmly and stably at the enzyme catalytic site. In conclusion, this study can provide important information on the development of herbal medicines that are potentially cancer drugs.

Keywords

Aurone, MMP-9 assay, Molecular docking, Molecular dynamic simulation, RMSD, RMSF